Mesenchymal stromal cells for treatment of graft versus host disease
This study compared the efficacy and safety of corticosteroid therapy with or without mesenchymal stromal cell (MSC) therapy in newly diagnosed acute graft versus host disease.
Read More
The trial was registered with the Australian and New Zealand clinical trials registry (ANZCTR12610000068066).
Read More
Product Information for
Mesenchymal stromal cells for treatment of graft versus host disease